Total Liabilities: The total value of all possible claims against the corporation.
Polaryx Therapeutics, Inc. (PLYX) had Total Liabilities of 0.60M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-8.98M |
|
-- |
|
-- |
|
7.82M |
|
-7.82M |
|
-1.16M |
|
-8.98M |
|
-8.98M |
|
-8.98M |
|
-8.98M |
|
-8.98M |
|
-8.98M |
|
-7.82M |
|
-7.82M |
|
45.42M |
|
45.42M |
|
-0.20 |
|
-0.20 |
|
| Balance Sheet Financials | |
5.17M |
|
-- |
|
-- |
|
5.17M |
|
0.60M |
|
-- |
|
-- |
|
|
Total Liabilities |
0.60M |
4.57M |
|
4.57M |
|
4.57M |
|
47.34M |
|
| Cash Flow Statement Financials | |
-3.94M |
|
-- |
|
4.47M |
|
4.62M |
|
5.14M |
|
0.52M |
|
4.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-196.82% |
|
-196.82% |
|
-173.79% |
|
-196.82% |
|
0.10 |
|
-0.09 |
|
-0.09 |
|